How cheap, popular drugs could be the secret weapon against dementia

Dementia is the UK's biggest killer, claiming more lives than heart attacks and strokes combined. Despite years of exhaustive research costing millions, science has failed to find a cure or drug to prevent it.Last year, data on a new drug - donanemab - suggested it could delay the worsening of symptoms in early Alzheimer's, while a similar drug, lecanemab, was almost as effective.But serious side-effects - a third of patients on donanemab suffered brain bleeds - and the prohibitive cost of £60,000 for an 18-month course meant neither was approved for 레비트라 구매 the NHS.Now, though, there are fresh hopes…